In terms of irinotecan-based regimens in cancers, UGT1A1*6 plays a more vital role in hematologic toxicity (p = 0.011) whereas UGT1A1*28 get more involved in diarrhea (p < 0.001).
No takes yet. Share an insight, caveat, or question.
Peng et al. (2017) studied this question.